510(k) K233391
K233391 is an FDA 510(k) premarket notification submitted by VPIX Medical, Inc. for the device "cCeLL - In vivo". The FDA issued a decision of Substantially Equivalent on August 21, 2024. The device falls under product code GWG (Endoscope, Neurological), a Class II device regulated under 21 CFR 882.1480. VPIX Medical, Inc. has at least 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 21, 2024
- Date Received
- October 2, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Endoscope, Neurological
- Device Class
- Class II
- Regulation Number
- 882.1480
- Review Panel
- NE
- Submission Type
If the device is reusable, validated reprocessing instructions and reprocessing validation data for this device type must be included in a 510(k) submission (82 FR 26807, available at https://www.gpo.gov/fdsys/pkg/FR-2017-06-09/pdf/2017-12007.pdf).